Cherry (C3RY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
4 Feb, 2026Q3/9M 2024 performance overview
Missed internal expectations due to overreliance on the German market and weak corporate and consumer spending.
Components segment impacted by a sluggish notebook market and order delays, resulting in a €13m revenue shortfall.
Adjusted EBITDA margin turned negative instead of the targeted 5-6%, with €6m cash burned in Q3.
Financial results
9M 2024 revenue reached €84m, with a gross profit hit of €6m impairing fixed cost coverage.
9M adjusted EBITDA was -€0.7m; Q3 adjusted EBITDA was -€3.1m, missing the €2m target.
Revenue and EBITDA declines were seen across GOP and Components, with Corporate and DH&S segments also underperforming.
Inventory and working capital management
Inventories reduced by 23% and trade working capital by 14% from Q1 2023 to Q3 2024.
Latest events from Cherry
- 2025 revenue fell 15% to €94.3M, with cost cuts, margin recovery, and segment review ongoing.C3RY
Q4 20255 Mar 2026 - 2024 guidance targets €140m–€150m revenue and a 7–8% EBITDA margin, signaling a strong turnaround.C3RY
Investor presentation4 Feb 2026 - Streamlined for margin-driven growth, with €120M 2024 revenue forecast and €3.5M cost savings.C3RY
Investor presentation4 Feb 2026 - Restructuring, M&A, and operational streamlining target a return to growth and financial stability.C3RY
Investor presentation4 Feb 2026 - Digital Health & Solutions growth and cost controls support outlook despite margin pressure.C3RY
Q2 20243 Feb 2026 - Q3 2024 results missed expectations, triggering restructuring and a cut in full-year guidance.C3RY
Q3 2024 TU19 Jan 2026 - Revenue and margins fell, but Q4 free cash flow rose as restructuring targets 2025 recovery.C3RY
Q4 2024 TU26 Dec 2025 - Restructuring and SaaS focus aim to restore profitability and drive growth in 2025.C3RY
Analyst Day 202525 Nov 2025 - 9M 2025 revenue down 16%, Q3 up 9.3% YoY; net loss widens amid restructuring.C3RY
Q3 2025 TU17 Nov 2025